Health tech company Hormona has raised a US$6.6m in its seed round that will drive the company’s expansion, help launch its innovative hormone tests, and grow...

Scientists have found that global warming in the Middle East and North Africa is making breast, ovarian, uterine, and cervical cancer more common and more deadly. ...

Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts, a new trial has found. In women with dense breasts (breasts...

New research has revealed that the use of combined oral contraceptives (OCs) is associated with a threefold increase in the risk of cryptogenic ischaemic stroke (CIS)...

Women with a higher McCance Brain Care Score (BCS) – a score that measures physical, lifestyle, and social-emotional factors – have a lower risk of experiencing...

The Royal College of Midwives (RCM) is calling for urgent investment in perinatal mental health support – not only in services, but also the midwives that provide them....

A new surgical approach aims to offer women a more natural breast shape following implant removal, without the need for fat transfer or replacement implants. The...

The Association of British HealthTech Industries (ABHI) has announced that only a handful of exhibition stands remain for WHX Dubai 2026, taking place 9–12 February at...

Merck’s immunotherapy drug Keytruda (pembrolizumab) has shown a “statistically significant” survival benefit in platinum-resistant ovarian cancer, potentially offering a new treatment path for patients with few...

British medical experts are raising concerns about the underrepresentation of women in clinical studies, The Guardian reports, with male-only trials outnumbering female-focused research by 67 per cent. Healthcare...